March 1st, TAVI is reimbursed for all symptomatic severe AS patients at intermediate risk if eligible by a Heart Team

Interventional Cardiologist, Dr. Matt Brooks, discusses what this means for treatment of symptomatic severe aortic stenosis patients and how it relates to the latest updates in international guidelines.

Guide your patients to a heart team to ensure TAVI is an option for them.

Collaborate with a Heart Team

No one knows your symptomatic severe aortic stenosis (SAS) patients like you do.

You have the power to care for these patients with urgency, so patients can get life-saving treatment they need, when they need.

Waiting increases the risk of sudden death2

After 6 months that pass without treatment, severe AS patients have over 10% risk of mortality due to complications of their disease.2 With those numbers in mind, you can trust your instincts, act urgently, and give your patients the treatment they need.

How Many of Your Patients May Be Left Untreated?

Select the estimated number of patients 75 and older you see per week:*

*Based on a 48-week working year. Number calculated from pooled prevalence of all severe aortic stenosis in the elderly (12.4%).12

Your SAS patients trust you to guide them to the right treatment

Unlock their best chance at greater outcomes by guiding all your patients with valvular heart disease to a Multidisciplinary Heart Valve Team for timely treatment evaluation.

Collaborate with a Heart Team

References:   1. Carabello BA. Introduction to Aortic Stenosis. Circ. Res 2013;113:179-185. 2. Malaisrie SC, McDonald E, Kruse J, et al. Mortality while waiting for aortic valve replacement. Ann Thorac Surg. 2014;98:1564-71. 4. Osnabrugge RL, Mylotte D, Head SJ, et al. Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. J Am Coll Cardiol. 2013;62(11):1002-1012.